Skip to Content

Join the 'Zirabev' group to help and get support from people like you.

Zirabev News

Atezolizumab-Bevacizumab Beats Sorafenib in Liver Cancer

WEDNESDAY, May 13, 2020 – Atezolizumab plus bevacizumab improves survival outcomes versus sorafenib in patients with unresectable hepatocellular carcinoma, according to a study published in the May...

Low Doses of Bevacizumab Tested for Retinopathy of Prematurity

FRIDAY, April 24, 2020 – For treatment of retinopathy of prematurity (ROP), 0.004 mg may be the lowest effective dose of bevacizumab, according to a study published online April 23 in JAMA...

FDA Medwatch Alert: Pacifico National, Inc. dba AmEx Pharmacy Issues Voluntary Nationwide Recall for all Lots of Bevacizumab

August 30, 2019 – AmEx Pharmacy today announces a voluntary recall of all Lots of Bevacizumab 1.25mg/0.05mL 31G Injectable and all Lots of Bevacizumab 2.5mg/0.1ml Normject TB Injectable that are...

FDA Approves Zirabev (bevacizumab-bvzr), a Biosimilar to Avastin

Friday, June 28, 2019 - Pfizer Inc. (NYSE:PFE) today announced the United States (U.S.) Food and Drug Administration(FDA) has approved Zirabev (bevacizumab-bvzr), a biosimilar to...

Ask a Question

Want to post your own question to this support group? You'll need to first create an account with Drugs.com (or sign in to your existing account).

Further Information

Related Condition Support Groups

Non-Small Cell Lung Cancer

Zirabev Patient Information at Drugs.com